Activation and desensitization by cyclic antidepressant drugs of α2-autoreceptors, α2-heteroreceptors and 5-HT1A-autoreceptors regulating monoamine synthesis in the rat brain in vivo

被引:58
作者
Esteban, S [1 ]
Lladó, J [1 ]
Sastre-Coll, A [1 ]
García-Sevilla, JA [1 ]
机构
[1] Univ Balearic Isl, Dept Biol, CSIC, Neuropharmacol Lab,Associate Unit Inst Cajal, E-07071 Palma de Mallorca, Spain
关键词
alpha(2C)-autoreceptors; alpha(2A)-heteroreceptors; 5-HT1A-autoreceptors; dopa/noradrenaline synthesis; 5-HTP/serotonin synthesis; cyclic antidepressant drugs; rat brain;
D O I
10.1007/s002109900045
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The effects of antidepressant drugs on the synthesis of noradrenaline and serotonin (5-HT) were assessed using the accumulation of 3,4-dihydroxyphenylalanine (dopa) and 5-hydroxytryptophan (5-HTP) after decarboxylase inhibition as a measure of the rate of tyrosine and tryptophan hydroxylation in the rat brain in vivo. Three inhibitory synthesis-modulating receptors were investigated simultaneously: the alpha(2C)-autoreceptor modulating dopa/noradrenaline synthesis, and the alpha(2A)-heteroreceptor and 5-HT1A-autoreceptor modulating 5-HTP/5-HT synthesis. Acute treatment (2 h, i.p.) with desipramine (1-10 mg/kg), protriptyline (0.3-10 mg/kg) and nisoxetine (3-10 mg/kg), selective NA reuptake blockers, dose-dependently decreased dopa synthesis in cortex (15%-40%) and hippocampus (20%-53%). Fluoxetine (1-10 mg/kg) and zimelidine (1-10 mg/kg), selective 5-HT reuptake blockers, did not alter dopa synthesis. Fluoxetine and zimelidine dose-dependently decreased 5-HTP synthesis in cortex (14%-3%) and hippocampus (27%-54%). Desipramine and protryptyline did not alter 5-HTP synthesis in cortex but in hippocampus it was decreased (36%). Repeated desipramine (10 mg/kg for 1-21 days) or fluoxetine (3 mg/kg for 3-21 days) treatment resulted in a time-dependent loss in their ability to decrease dopa or 5-HTP synthesis. Desipramine (1-21 days) did not alter 5-HTP synthesis in cortex, but in hippocampus it was decreased (21%-37%, days 1-14) followed by recovery to control values (day 21). Fluoxetine (3-21 days) did not alter brain dopa synthesis. To further assess the desensitization of alpha(2C)-autoreceptors, alpha(2A)-heteroreceptors and 5-HT1A autoreceptors regulating the synthesis of dopa/NA or 5-HTPI 5-HT after chronic desipramine and fluoxetine, the effects of clonidine (agonist at alpha(2)-auto/heteroreceptors) and 8-OHDPAT (agonist at 5-HT1A-autoreceptors) were tested. In saline-treated rats, clonidine (1 mg/kg, 1 h) decreased dopa and 5-HTP synthesis in cortex (58% and 54%) and hippocampus (54% and 42%). In desipramine-treated rats (10 mg/kg, 21 days), but not in fluoxetine-treated ones (3 mg/kg, 14 days), the effect of clonidine was attenuated in cortex (12% and 18%) and only for dopa synthesis in hippocampus (31%). In saline-treated rats, 8-OH-DPAT (1 mg/kg, 1 h) decreased 5-HTP synthesis in cortex (63%) and hippocampus (75%). In fluoxetine-treated rats, but not in desipramine-treated ones, this inhibitory effect was markedly attenuated in cortex (26%) and hippocampus (9%). These findings indicate that acute treatment with cyclic antidepressant drugs results in activation of inhibitory alpha(2C)-autoreceptors, alpha(2A)-heteroreceptors and/or 5-HT1A-autoreceptors regulating the synthesis of dopa/NA and/or 5-HTP/5-HT in brain, whereas chronic treatment with these drugs is followed by desensitization of these presynaptic receptors.
引用
收藏
页码:135 / 143
页数:9
相关论文
共 48 条
[1]   REGIONAL DISTRIBUTION OF EXTRACELLULAR 5-HYDROXYTRYPTAMINE AND 5-HYDROXYINDOLEACETIC ACID IN THE BRAIN OF FREELY MOVING RATS [J].
ADELL, A ;
CARCELLER, A ;
ARTIGAS, F .
JOURNAL OF NEUROCHEMISTRY, 1991, 56 (02) :709-712
[2]   Acceleration of the effect of selected antidepressant drugs in major depression by 5-HT1A antagonists [J].
Artigas, F ;
Romero, L ;
deMontigny, C ;
Blier, P .
TRENDS IN NEUROSCIENCES, 1996, 19 (09) :378-383
[3]  
ARTIGAS F, 1994, ARCH GEN PSYCHIAT, V51, P248
[4]  
AUERBACH SB, 1995, N-S ARCH PHARMACOL, V352, P597
[5]   INTERACTIONS OF FLUOXETINE WITH METABOLISM OF DOPAMINE AND SEROTONIN IN RAT-BRAIN REGIONS [J].
BALDESSARINI, RJ ;
MARSH, ER ;
KULA, NS .
BRAIN RESEARCH, 1992, 579 (01) :152-156
[6]  
BARTUREN F, 1992, MOL PHARMACOL, V42, P846
[7]   MODULATION OF 5-HT RELEASE IN THE GUINEA-PIG BRAIN FOLLOWING LONG-TERM ADMINISTRATION OF ANTIDEPRESSANT DRUGS [J].
BLIER, P ;
BOUCHARD, C .
BRITISH JOURNAL OF PHARMACOLOGY, 1994, 113 (02) :485-495
[8]  
BYLUND DB, 1994, PHARMACOL REV, V46, P121
[9]  
Callado LF, 1998, J NEUROCHEM, V70, P1114
[10]   SIMULTANEOUS MEASUREMENT OF TYROSINE AND TRYPTOPHAN HYDROXYLASE-ACTIVITIES IN BRAIN IN-VIVO USING AN INHIBITOR OF AROMATIC AMINO-ACID DECARBOXYLASE [J].
CARLSSON, A ;
ATACK, CV ;
LINDQVIST, M ;
KEHR, W ;
DAVIS, JN .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1972, 275 (02) :153-+